Great DD!
Patents Assigned to Regen BioPharma, Inc
Modulation of NR2F6 and methods and uses thereof
Patent number: 9091696
Abstract: The application provides methods of modulating NR2F6 in a cell or animal in need thereof by administering an effective amount of a NR2F6 modulator.
Type: Grant
Filed: October 15, 2012
Date of Patent: July 28, 2015
Assignee: Regen Biopharma, Inc.
Inventors: Christine Victoria Ichim, Richard Alexander Wells
So the grant on that patent I’m assuming is what has made this stock move recently?